Prevention of Relapses in Proteinase 3 (PR3)-Anti-neutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis
NCT00128895
·
clinicaltrials.gov ↗
PHASE4
Phase
TERMINATED
Status
131
Enrollment
OTHER
Sponsor class
Conditions
Vasculitis
Interventions
DRUG:
azathioprine
Sponsor
University Medical Center Groningen
Collaborators
[object Object]
[object Object]
[object Object]